换一批
换一批Antiplatelets in secondary stroke prevention.
摘要：
The aim of this review is to provide evidence-based recommendations on the secondary prevention of atherothrombotic ischemic stroke. Antiplatelets are the major therapy for the secondary stroke prevention. The most commonly used antiplatelets agents are aspirin, clopidogrel, and extended-release dipyridamole. A lot of progress had been made in last years regarding aspirin resistance and genotyping of clopidogrel metabolism. According to the results of the accomplished studies it is difficult to broadly recommend one antithrombotic agent in favor of the other. Instead, a review of the currently published data suggests the importance of focusing on the individualizing approach in antiplatelet therapy.
更多
作者：
Olga,Shulga [1]
;
Natan,Bornstein [2]
作者单位：
Department of Neurology
[1]
Volyn Regional Clinical Hospital Lutsk
[2]
Ukraine.
[3]
期刊：
DOI：
10.3389/fneur.2011.00036
PMID：
21772826
发布时间：
2021-10-20
- 翻译满意度评价：
- 提交
- 浏览：0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
